Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/42864
Title: | The Monoselective Sphingosine-1-Phosphate Receptor-1 Modulator Ponesimod Enhances Remyelination in the Cuprizone Model of Demyelination | Authors: | WILLEMS, Emily SCHEPERS, Melissa Ait-Tihyaty, M. VANMIERLO, Tim |
Issue Date: | 2023 | Publisher: | WILEY | Source: | GLIA, 71 (S1) , p. E791 | Abstract: | Background: Sphingosine-1-phosphate (S1P1) receptor modulators are used clinically to treat relapsing forms of multiple sclerosis (MS). Selective functional antagonism of the S1PR1 subtype by ponesimod prevents lymphocyte egression from lymph nodes, hence hampering neuroinflammation in MS. Recent findings suggest a potential additional role for ponesimod in the Central Nervous System (CNS) in the differentiation of oligodendrocyte precursor cells (OPC) into mature myelinating oligodendrocytes, and therefore potentially having some effects on remyelination. | Document URI: | http://hdl.handle.net/1942/42864 | ISSN: | 0894-1491 | e-ISSN: | 1098-1136 | ISI #: | 001191372500660 | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Poster Presentations.pdf Restricted Access | Published version | 356.13 kB | Adobe PDF | View/Open Request a copy |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.